Clinical trial
The Influence of the Pre-Therapeutic Increase in the Hemoglobin Level in the Blood Through Erythropoietin to the Therapy Results of the Primary Radiation Therapy for Carcinoma of the Cervix
NCT00348738 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Influence of the Pre-Therapeutic Increase in the Hemoglobin Level in the Blood Through Erythropoietin to the Therapy Results of the Primary Radiation Therapy for Carcinoma of the Cervix
- Lead sponsor
- Medical University of Vienna
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- July 31, 2000
- Completion date
- July 31, 2009
- Enrollment
- 300 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
cervix cancer